Latest News

November 7, 2024

Press Release: ECOG-ACRIN and PrECOG announce multiple presentations at ASH 2024

October 30, 2024

ECOG-ACRIN and Caris partner to learn more from the TAILORx trial

October 30, 2024

WATCH: Behind the ECOG-ACRIN E1910 trial with lead investigator Dr. Mark Litzow

October 29, 2024

WATCH: Breast Cancer Research Foundation hosts Dr. Joseph Sparano and Amanda Quick of The Pink Agenda to discuss metastatic breast cancer

October 25, 2024

ECOG-ACRIN Lymphoma Committee co-chair Andrew Evens comments on the results of the SWOG study S1826, Nivolumab-AVD in Advanced-Stage Classic Hodgkin Lymphoma

October 25, 2024

ECOG-ACRIN and Caris to analyze samples from TAILORx (requires free registration)

October 24, 2024

The October 2024 News from ECOG-ACRIN blog is now available

October 24, 2024

Press Release: ECOG-ACRIN and Caris Life Sciences partner to interrogate landmark TAILORx breast cancer trial

October 23, 2024

Press Release: myeloMATCH precision medicine trials in myeloid leukemias open to patient enrollment across the US and Canada


About Us

The ECOG-ACRIN Cancer Research Group is a strong network of nearly 1300 academic and community-based cancer centers and hospitals in the United States and around the world. We design and conduct biomarker-driven research involving adults who have or are at risk of developing cancer. Learn More


Home

Scientific Pursuits

We are dedicated to improving life for adults affected by cancer. Through our member sites, we are pursuing a robust clinical and translational research portfolio that focuses on precision oncology, immunotherapy, reducing over-treatment and over-diagnosis, leveraging novel biomarker platforms to inform therapeutic decision-making, and advancing standards of care in broad populations of cancer patients and those at risk. Learn More


ECOG-ACRIN by the Numbers

Home
44

Active Clinical Trials

Home
1400

Participating Institutions

Home
67

International Sites

Home
21000

Individual Members


Scientifically rigorous, broadly multidisciplinary, organizationally robust, and internationally respected, the Group is a vibrant component of the National Cancer Institute (NCI) National Clinical Trials Network (NCTN). In addition, we are a Research Base in the NCI Community Oncology Research Program (NCORP).

ECOG-ACRIN Cancer Research Group